Quarter Period Consolidated Statement Of Comprehensive Income

Immuno-Biological Laboratories Co., Ltd. - Filing #7370747

Concept 2023-04-01 to
2023-09-30
2022-04-01 to
2022-09-30
Quarter period consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
26,861,000 JPY
-136,168,000 JPY
Comprehensive income
26,861,000 JPY
-136,168,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
26,861,000 JPY
-136,168,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.